4/11/25 18:12  | 4/9/25  | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT |  | P.m | 2,299 | 16.20 | 0 | 142 | 2 | 6,024 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/9/25 17:38  | 4/7/25  | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT |  | P | 8,550 | 17.10 | 0 | 500 | 9 | 5,882 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/7/25 17:02  | 4/7/25  | TECX | Health | BioPrd | Biological Products, (No Diag | McGuire Terrance | MA | D |  | S | -8,550 | 17.10 | 0 | -500 | -43 | 658 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/7/25 16:21  | 2/5/25  | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT |  | P | 40,000 | 50.68 | 0 | 789 | 17 | 5,382 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/7/25 16:19  | 2/5/25  | TECX | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | MA | O | CFO | P | 250 | 54.14 | 0 | 5 | New | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/29/25 16:05  | 1/28/25  | TECX | Health | BioPrd | Biological Products, (No Diag | Schwabish Marc | MA | O | Chief Bu | M.d | 6 | 2.38 | 0 | 3 | 135 | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/11/24 16:21  | 12/9/24  | TECX | Health | BioPrd | Biological Products, (No Diag | Schwabish Marc | MA | O | Chief Bu | M.d | 5 | 2.38 | 0 | 2 | New | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/5/24 16:32  | 12/3/24  | TECX | Health | BioPrd | Biological Products, (No Diag | McNamara Peter | MA | O | Chief Sc | M.d | 8 | 2.38 | 0 | 4 | 33 | 14 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/24/24 17:04  | 10/22/24  | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT |  | P | 10,077 | 33.59 | 0 | 300 | 7 | 4,593 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/26/24 18:15  | 9/26/24  | TECX | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT |  | P | 1,441 | 28.82 | 0 | 50 | 1 | 4,293 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/15/24 11:21  | 5/13/24  | AVRO | Health | BioPrd | Biological Products, (No Diag | Leonard Braden Michael | IN | T |  | P.m | 971 | 1.27 | 0 | 767 | 17 | 5,168 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/24 20:01  | 2/1/24  | AVRO | Health | BioPrd | Biological Products, (No Diag | Golipour Azadeh | MA | O | CTO | M.d | 0 | 0.00 | 0 | 37 | 201 | 56 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/24 19:59  | 2/1/24  | AVRO | Health | BioPrd | Biological Products, (No Diag | Ridha Essra | MA | O | Chief Me | M.d | 0 | 0.00 | 0 | 33 |  | 16 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/24 19:57  | 2/1/24  | AVRO | Health | BioPrd | Biological Products, (No Diag | Ostrowski Erik | MA | O | Interim  | M.d | 0 | 0.00 | 0 | 40 |  | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/5/24 19:56  | 2/1/24  | AVRO | Health | BioPrd | Biological Products, (No Diag | Avruch Steven | MA | O | GC | M.d | 0 | 0.00 | 0 | 33 |  | 22 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/26/23 17:30  | 1/24/23  | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 42 | 0.9100 | 0 | 46 | 6 | 778 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/28/22 19:18  | 12/23/22  | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 59 | 0.4132 | 0 | 142 | 24 | 732 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/8/21 16:21  | 7/7/21  | AVRO | Health | BioPrd | Biological Products, (No Diag | Vickers Philip J. | MA | D |  | P | 40 | 8.35 | 0 | 5 | New | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/18/21 19:06  | 2/17/21  | AVRO | Health | BioPrd | Biological Products, (No Diag | Donenberg Phillip B. | MA | D |  | P | 23 | 11.71 | 0 | 2 | New | 2 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/28/20 19:46  | 12/24/20  | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | P,CEO | M.d | 41 | 0.4132 | 0 | 100 | 20 | 590 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/14/20 19:16  | 2/12/20  | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S | -41 | 29.07 | 0 | -1 | 0 | 490 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/11/20 21:26  | 2/11/20  | AVRO | Health | BioPrd | Biological Products, (No Diag | Paige Christopher | MA | D |  | S | -420 | 28.00 | 0 | -15 | -6 | 253 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/11/20 21:23  | 2/11/20  | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S | -1,737 | 27.57 | 0 | -63 | -11 | 492 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/30/20 16:10  | 1/28/20  | AVRO | Health | BioPrd | Biological Products, (No Diag | Paige Christopher | MA | D |  | S | -230 | 23.00 | 0 | -10 | -4 | 268 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/23/19 16:09  | 7/19/19  | AVRO | Health | BioPrd | Biological Products, (No Diag | Atlas Venture Fund X, L.P. | MA | T |  | P | 15,000 | 18.50 | 0 | 811 | 17 | 5,567 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/23/19 16:09  | 7/19/19  | AVRO | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D |  | P | 15,000 | 18.50 | 0 | 811 | 17 | 5,567 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/9/19 16:39  | 4/5/19  | AVRO | Health | BioPrd | Biological Products, (No Diag | Paige Christopher | MA | D |  | S.m | -257 | 25.72 | 0 | -10 | -3 | 278 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/9/19 16:27  | 4/5/19  | AVRO | Health | BioPrd | Biological Products, (No Diag | Mackay Geoffrey | MA | DO | See Rema | S.m | -382 | 27.25 | 0 | -14 | -2 | 555 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/10/18 18:11  | 10/8/18  | AVRO | Health | BioPrd | Biological Products, (No Diag | Dorton Katina | MA | O | CFO | M.d | 9 | 0.9100 | 0 | 10 | New | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/10/18 18:05  | 10/8/18  | AVRO | Health | BioPrd | Biological Products, (No Diag | Kreher Nerissa | MA | O | Chief Me | M.d | 3 | 0.9100 | 0 | 3 | New | 3 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |